Robert A. Cormack
Dana-Farber Cancer Institute, Harvard University, Tufts Medical Center
Papers
4
Total Citations
279
H-Index
3
About
Robert A. Cormack is a leading figure in the advancement of precision radiation oncology, with his research fundamentally reshaping how cancer therapies are delivered. His work centers on two transformative areas: the integration of robotics into brachytherapy and the application of nanotechnology for targeted radiotherapy. Dr. Cormack’s most significant contribution is his leadership in developing the AAPM and GEC-ESTRO guidelines for image-guided robotic brachytherapy (Task Group 192), a seminal framework that has standardized the validation and clinical adoption of robotic seed implantation systems. This work, cited nearly 100 times, provides the essential protocol for ensuring the spatial accuracy and precision needed to optimize tumor control while minimizing damage to healthy tissue. Further demonstrating his innovative reach, his highly cited paper on gold nanoparticles (168 citations) explores their potential to enhance radiation dose delivery at the cellular level, opening new frontiers in targeted therapy. Through these contributions, Dr. Cormack has not only established the benchmarks for modern brachytherapy but also paved the way for next-generation, automated, and nanoscale cancer treatments.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4